HER2-0 is now defined by a complete absence of staining in infiltrating tumor cells, HER2 ultra-low by ≤10% of cells with faint or weak membrane staining and HER2-low by an IHC score of 1+ or 2+ with a negative in situ hybridization (ISH) result. This evidence concerns the gene ERBB2 and neoplasm.